CANC vs XBI

Tema Oncology ETF against State Street SPDR S&P Biotech ETF: cost, size, returns, what they hold and how much of it is the same.

Overlap by weight
25%
37 shared positions
Fee gap
40 bp
XBI is cheaper
1-year return gap
2.4 pts
XBI is ahead
Larger fund
XBI
$10.4B

Side by side

CANCXBI
FundTema Oncology ETFState Street SPDR S&P Biotech ETF
IssuerTemaState Street SPDR
CategoryBiotech & Health InnovationBiotech & Health Innovation
Expense ratio0.75%0.35%
Assets$176M$10.4B
Average daily dollar volume$1.2M$1.5B
ListedAug 14, 2023Jan 31, 2006
FrenzyCap score3696
1-month return−3.0%−5.6%
3-month return+0.5%+0.4%
Year to date+19.6%+25.3%
1-year return+36.3%+38.7%
30-day volatility26.2%31.8%
Worst drawdown, 1 year−13.2%−14.9%
Trailing 12-month yield0.05%0.36%
Holdings61167
Top 10 weight40.0%17.8%
Look-through P/E——
Holdings vs fair value+6.0%+10.3%
Holdings above 200-day average67%59%
Net flow, latest 3 reported months+$14M thru May 2026+$1.3B thru Jun 2026
30-day implied volatility—32.7%
Holdings as ofas of Oct 1, 2026third-party dataas of Oct 20, 2026issuer data

Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.

Largest shared holdings

55% of CANC · 30% of XBI
HoldingCANCXBI
HALO3.05%1.71%
ABBV3.34%1.70%
IOVA3.24%1.67%
EXEL3.12%1.63%
RVMD5.58%1.40%
BBIO2.41%1.31%
AMGN1.30%1.66%
NTRA1.24%1.82%
ERAS1.91%1.23%
COGT4.73%1.22%
GILD1.07%1.59%
CGON2.63%0.95%
RLAY2.02%0.90%
CELC1.60%0.72%
TNGX0.68%1.03%
SMMT1.42%0.58%
MRNA0.58%2.64%
IDYA2.67%0.56%
RCUS1.09%0.49%
TWST0.35%1.68%
IMNM2.40%0.35%
ORIC0.69%0.33%
INBX0.69%0.31%
ANAB0.79%0.29%
REPL0.72%0.28%

Sector mix of the stock holdings

SectorCANCXBIGap
Health Care92.6%99.3%−6.7%
Financials0.0%0.5%−0.5%

More: full overlap table · CANC holdings · XBI holdings

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.